Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Natera

Explore full profile

Harnessing the power of DNA to improve the management of reproductive health, cancer, and organ transplants

Austin, United StatesFounded 2004Biotech & Life Sciences
Valuation $38B Market cap · Aug/2026
Revenue $2.80B Latest reported FY

At a glance

Status
Listed
Founded
2004
Headquarters
Austin, United States
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later11 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 5,885 incl. 81 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 32 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 8 startups shown

Former Natera employees who went on to found companies, sorted by Dealroom signal score.

DatavantEst. 2017
Sam RooszUnited States
Signal score79
GigaGenEst. 2010
David JohnsonUnited States
Signal score78
CentinusEst. 2023
Jonathan SheenaUnited States
Signal score78
Curve BiosciencesEst. 2021
Nathan HunkapillerUnited States
Signal score68
Silverback TherapeuticsEst. 2016
Badreddin EdrisUnited States
Signal score62
3 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
40 countries with
team presence
🇺🇸 United States95.4%
🇷🇸 Serbia1.7%
🇷🇺 Russia0.6%
🇨🇦 Canada0.3%
🇬🇹 Guatemala0.2%
Top 5 of 40 shown
Web traffic by country
1.2M monthly visits
across markets
🇺🇸 United States92.3%
🇩🇪 Germany1%
🇮🇳 India0.8%
🇹🇷 Turkey0.5%
🇨🇦 Canada0.4%
Top 5 markets shown

Patents

Estimated portfolio value
$54M

59 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Natera was the backer or acquirer, 2022–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

2 deals across Natera's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Natera deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Natera's portfolio, mapped.

        Stage
        Period
        2 of 2 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Natera on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Natera on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles